UTL-5g | Interleukin Related interleukin-related.com

Product Name :
UTL-5g

Search keywords :
UTL-5g

drugId :
null

Target Vo:
Tumor necrosis factor α

Target Vo Short Name :
TNFα

Moa_Name:
Tumor necrosis factor α inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
21st Century Therapeutics Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Radiation Injuries

Termination Status :
Preclinical

China Termination Status :
Preclinical

Highest Status:
Pending

China Highest Status:
Pending

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FACL4 Antibody
IRF3 Antibody
NIS Antibody: NIS Antibody is an unconjugated, approximately 68 kDa, rabbit-derived, anti-NIS polyclonal antibody. NIS Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in mouse, rat, and predicted: human background without labeling.

Author: Interleukin Related

Related Posts